State-of-the-art testing technologies

Quest Diagnostics uses the most up-to-date technology for enhanced identification for use of opioids, benzodiazephines, and other drugs.

medMATCH® Reports

Get a clear picture of patient compliance with our optional medMATCH reports

Our expert toxicologists, MDs, and PhDs share unique insights, research, and latest trends in drug monitoring and impact on the drug epidemic across the nation.

Drug testing blog: unique insights & research you can’t get anywhere else

Full-Spectrum CBD May Trigger Positive THC Result

Use of so-called “full-spectrum” formulations of cannabidiol (CBD) products can cause users to test positive for THC, the component of marijuana that causes euphoria, according to an open-label study published in JAMA Psychiatry.

Quanum™ for Healthcare Professionals: insights that inform your decisions

Our Quanum™ for Healthcare Professionals can help drive improved efficiencies in obtaining, sharing, and integrating health information. Features like 3-click test ordering, online supply ordering and report sharing can help you spend less time on paperwork and more time with your patients.

Quest Diagnostics Clinical Drug Monitoring